|
|
 |
| Àâòîðèçàöèÿ |
|
|
|
| Ïîèñê ïî óêàçàòåëÿì |
|
|
|
|
|
|
|
 |
|
|
|
| Lanza R. (ed.), Weissman I. (ed.), Thomson J. (ed.) — Handbook of Stem Cells (vol. 1) Embryonic Stem Cells |
|
|
|
| Ïðåäìåòíûé óêàçàòåëü |
Stem cell factor in hematopoietic stem cell expansion 2: 622—623
Stem cell factor in hepatic stem cell activation 2: 505—506
Stem cell factor in primordial germ cell proliferation 1: 451 1:
Stem cell factor, hematopoietic stem cell mobilization induced by 2: 595 2:
Stem cell niche 1: 158
Stem cell niche in spermatogenesis 1: 175—177
Stem cell niche in tooth 1: 265—270
Stem cell niche, animal models 2: 59—60 2:
Stem cell niche, biological significance 1: 171 1: 2: 2:
Stem cell niche, cardiac 2: 711—713
Stem cell niche, cell adhesion 2: 62—63 2: 2:
Stem cell niche, cell fate signaling pathways in 2: 60—62 2:
Stem cell niche, conceptual model 2: 59 2:
Stem cell niche, epidermal 2: 65—67
Stem cell niche, future research 2: 38
Stem cell niche, gap junction signaling in 2: 63
Stem cell niche, hematopoietic 2: 64—65 2:
Stem cell niche, lung 2: 551—552
Stem cell niche, microarray analysis 2: 648
Stem cell niche, muscle stem cells 2: 399—400
Stem cell niche, orientation of stem cell division and 1: 175—176
Stem cell niche, ovarian stem cell division in 1: 159—164
Stem cell niche, testis 2: 63—64
Steroidogenic cells 1: 350—351
Steroids in neurogenesis 2: 221
Steroids in thymus involution 1: 679—680
Stochastic cell fate regulation 2: 26
Stomach 2: 522
Stomach, endoderm development 1: 379
STOP sequence 1: 617
Stroke 1: 246
Stromal cell database 2: 32
Stromal cell-derived factor 1: 189 2:
Stromal cells 1: 233
Stromal cells in neural induction of ES cells 1: 240—241
Stromal cells in osteoclast induction 1: 297 1:
Stromal cells, bone and marrow development 2: 415 2: 2:
Stromal cells, differentiation 2: 419—420
Stromal cells, stem cell kinetics in 2: 417
Submucosal glands 2: 547 2:
Suicide genes 1: 543 1: 1: 2:
Supravital fluorescent probes 2: 611
Sweat glands 2: 245
SWI/SNF complex 1: 70—72
Syncytiotrophoblast 1: 150 2:
Syngeneic transplant 2: 685
Synthetic microchromosomes 2: 792—793
T cells in graft rejection 1: 666 1: 2:
T cells in hematopoietic stem cell transplantation 2: 739 2:
T cells, age-related changes 2: 745 2:
T cells, development 2: 95—96 2: 2:
T cells, development, common lymphoid progenitor in 2: 357—358
T cells, disorders of 2: 555
T cells, extrathymic 2: 747
T cells, immune reconstitution 2: 751—754
T cells, immune regulation 2: 747—748
T cells, major histocompatibility complex interaction 1: 664 1: 1:
T cells, origin 2: 347 2: 2: 2:
T cells, positive/negative selection 1: 665 1:
T cells, proliferation and differentiation 1: 675—676 1:
T cells, receptor excision circles 2: 746—747
T cells, thymus development 2: 168 2:
T cells, thymus function in regulation of 2: 555
Tag-and-exchange method 1: 547
Tamoxifen 1: 613—614
TATA-binding protein 1: 66—67
Tcf complexes 2: 66 2: 2:
Tcf complexes in gastrointestinal development 1: 362—363
Tcf complexes in skin development 2: 263
Teeth, cell populations 1: 265 2:
Teeth, cell populations, epithelia stem cells 2: 282—284
Teeth, cell populations, mesenchymal stem cells 2: 284—285
Teeth, development 1: 265—270 2: 2:
Teeth, enamel 2: 279 2:
Teeth, evolutionary model 1: 268
Teeth, function 2: 279
Teeth, incisors 1: 266—267
Teeth, molars 1: 266f 1:
Teeth, regeneration strategies 2: 282 2:
Teeth, roots 1: 267—268
Teeth, stem cell niche 1: 265—270
Teeth, structure 2: 279 2: 2:
Teeth, tissue engineering 2: 785—786
Telomerase as stem cell marker 2: 250
Telomerase in bone marrow stromal cells 2: 417
Telomerase in cardiomyocytes 2: 451
Telomerase in ES cells 2: 128
Telomerase in hematopoietic stem cell regulation 2: 340
Telomerase in stem cell regulation 2: 130—131
Telomerase, aging effects 2: 340
Telomerase, assembly 2: 131
Telomerase, disorders of 2: 127 2:
Telomerase, function 2: 127 2:
Telomerase, nuclear localization 2: 131
Telomerase, structure 2: 130
Telomerase, transcription regulation 2: 130
Telomere shortening in somatic cell nuclear transfer clones 1: 625
Telomeres in hematopoietic system 2: 127 2:
Telomeres in multipotent adult progenitor cells 2: 293
Telomeres in stem cell biology 2: 133
Telomeres, age-related changes 2: 127—128 2: 2:
Telomeres, alternative lengthening 2: 131
Telomeres, binding proteins 2: 131
Telomeres, function 2: 127—128 2: 2:
Telomeres, length regulation 2: 128—131 2:
Telomeres, oxidative damage 2: 129—130
Telomeres, research needs 2: 129
Telomeres, structure 2: 127
Tendon, injury response 2: 775—776
Tendon, tissue-engineered repair 2: 303 2:
Teratocarcinomas 1: 46 1:
Teratocarcinomas, early stem cell research 1: 15—16
Teratomas from ES/ESL cells 1: 20
Teratomas to assess pluripotency 1: 20
Teratomas, early stem cell research 1: 15
Teratomas, vascularization 1: 324 1:
Testis, embryonic development 1: 346—348 1:
Testis, embryonic development, cell types 1: 352
Testis, genital ridge development 1: 189
Testis, germ line stem cell niches, Drosophila 2: 61—63 2:
Testis, germ line stem cell niches, mammalian 2: 63—64
Testis, transcript development in 1: 179 1:
Testosterone 1: 350
Tet-On/Tet-Off system 1: 583
Tetracycline repressor 1: 613—614
TH gene knockin 1: 554 1:
Thalassemia 2: 791
Theca cells 1: 350 1:
Therapeutic cloning 1: 669 1:
Therapeutic cloning, ethical guidelines 1: 762—763
Therapeutic cloning, ethical issues 1: 761—762
Therapeutic cloning, potential 2: 3
Therapeutic interventions from Xenopus animal cap cultures 1: 490—491 (see also “Transplantation medicine”)
Therapeutic interventions, adult stem cell applications 2: 16—17
Therapeutic interventions, animal disease models 2: 681
Therapeutic interventions, autoimmune disease 2: 754
Therapeutic interventions, blood disorders 2: 791
Therapeutic interventions, bone disease 2: 773
Therapeutic interventions, cell fusion applications 2: 155—156
Therapeutic interventions, chemotherapy adjunct treatment 2: 621—622
Therapeutic interventions, circulatory disorders 2: 455 2:
Therapeutic interventions, commercial potential 2: 813—818
Therapeutic interventions, commercial research and development 1: 787—792
Therapeutic interventions, craniofacial reconstruction 1: 229
Therapeutic interventions, diabetes management 1: 723—727 2:
Therapeutic interventions, ear problems 1: 253 1:
Therapeutic interventions, eosinophil-mediated disorders 1: 591
Therapeutic interventions, eye problems 1: 253 1:
Therapeutic interventions, Food and Drug Administration recommendations 2: 803—811
Therapeutic interventions, gastrointestinal inflammatory disorders 2: 529—530
| Therapeutic interventions, genetic defect disorders 1: 424
Therapeutic interventions, genetic manipulation techniques 1: 543 1: 1: 2:
Therapeutic interventions, genome sequencing and 2: 95
Therapeutic interventions, heart disease 1: 713—714 1: 1:
Therapeutic interventions, immunological challenges 1: 663
Therapeutic interventions, kidney failure 2: 479—480
Therapeutic interventions, lung injury/disease 1: 379 1:
Therapeutic interventions, male fertility 1: 179
Therapeutic interventions, mesenchymal stem cell applications 2: 302—305
Therapeutic interventions, mesenchymal stem cell applications, orthopedic 2: 771—778
Therapeutic interventions, muscular dystrophy 2: 721—727
Therapeutic interventions, neural crest cell application 1: 228—229
Therapeutic interventions, neurological 1: 245—247 1: 1: 1: 2: 2:
Therapeutic interventions, neurological, neural stem cell potential applications 1: 688—689 1:
Therapeutic interventions, orthopedic 2: 771—778
Therapeutic interventions, potential of controlled transdifferentiation 2: 139 2: 2:
Therapeutic interventions, proangiogenic stem cell recruitment 2: 383
Therapeutic interventions, regeneration of inner ear tissues 1: 258—260
Therapeutic interventions, regulatory controls 1: 775—785
Therapeutic interventions, skin injury 1: 732—735 2: 2:
Therapeutic interventions, spinal cord injury 1: 701 1:
Therapeutic interventions, stem cell potency assays 2: 806
Therapeutic interventions, tooth regeneration 2: 282 2:
Therapeutic interventions, use of amniotic fluid-derived cells 2: 175—179
Therapeutic interventions, use of common myeloid progenitors 2: 368—369
Therapeutic interventions, use of epidermal stem cells 2: 247—248
Therapeutic interventions, use of hematopoietic stem cells 1: 521 2: 2:
Therapeutic interventions, use of keratinocyte stem cells 2: 761
Therapeutic interventions, use of mesenchymal stem cells 2: 303—305 2:
Therapeutic interventions, use of neural crest cells 2: 215
Therapeutic interventions, use of processed lipoaspirate cells 2: 439—440
Three amino acid loop extension proteins 2: 633
Thrombin 2: 452
Thymocytes, development 1: 675—676 1:
Thymocytes, germ/stem cell hybrids 1: 660
Thymocytes, induction of immune tolerance by manipulation of 1: 680—682
Thymocytes, nuclear transfer cloning from 1: 644 (see also “T cells”)
Thymus, age-related changes 1: 675 1:
Thymus, common lymphoid progenitor cells in 2: 351—352
Thymus, development 1: 676—677 2:
Thymus, development, cell specification for 1: 393
Thymus, development, epithelial cell differentiation 1: 393 1: 1: 1:
Thymus, development, evolutionary aspects 1: 397—398
Thymus, development, germ layer origin 2: 556
Thymus, development, intercellular signaling in 1: 394—395
Thymus, development, islet formation 2: 559
Thymus, development, lymphocyte progenitor cell colonization 1: 398—399
Thymus, development, mesenchyme in 2: 556
Thymus, development, model 1: 391 1:
Thymus, development, molecular control, 1: 392f 2: 556—557
Thymus, development, mutations affecting 2: 556—557
Thymus, development, pharyngeal pouch and 1: 391—393
Thymus, development, primordia 1: 395—397
Thymus, development, progenitor cells 2: 555 2:
Thymus, development, separation and migration of rudiments 1: 397 1:
Thymus, development, structure 1: 675
Thymus, development, terminal differentiation 1: 399—41-02
Thymus, development, thymus epithelial cells in 2: 558—559 2: 2:
Thymus, development, transcription regulation 1: 393—394
Thymus, epithelial cells 2: 558—559 2: 2:
Thymus, epithelial cells in thymus organogenesis 2: 558—559 2: 2:
Thymus, epithelial cells, differentiation 1: 393 1: 1: 1: 2:
Thymus, epithelial cells, function 2: 555
Thymus, epithelial cells, grafting 2: 558
Thymus, epithelial cells, medullary 2: 559 2: 2:
Thymus, epithelial cells, molecular and cellular control 2: 556—557
Thymus, epithelial cells, precursors 2: 558
Thymus, epithelial cells, techniques for manipulating 2: 557—558
Thymus, function 2: 555
Thymus, regenerative capacity 1: 679—680 1:
Thymus, strategies for immune tolerance induction 1: 680—682
Thymus, T cell formation 1: 675—676 1: 2: 2: 2: 2:
Thyroid development 1: 379
Thyroid transcription factor, in lung development 1: 379 1:
Tissue engineering 2: 783—789
Tissue engineering, amniotic fluid progenitor cells in 2: 178
Tissue engineering, bladder replacement 2: 565—570
Tissue engineering, bone repair 2: 303 2: 2:
Tissue engineering, cell expansion for 2: 784—785
Tissue engineering, cell isolation for 1: 740—741
Tissue engineering, cell plasticity for 2: 783
Tissue engineering, challenges in stem cell research 1: 737 1: 1: 2:
Tissue engineering, clinical applications 1: 737—739
Tissue engineering, ES cell use in 1: 737
Tissue engineering, ES cell use in, differentiation issues 1: 739—740
Tissue engineering, ES cell use in, mass culturing 1: 741
Tissue engineering, fetal 2: 568—569
Tissue engineering, future prospects 2: 778 2:
Tissue engineering, implications of transdifferentiation 2: 141—142
Tissue engineering, limitations 1: 741—742
Tissue engineering, mesenchymal stem cells in 2: 302—305 2:
Tissue engineering, muscle regeneration 2: 786
Tissue engineering, osteochondral 2: 435—41—36
Tissue engineering, requirements for clinical success 2: 771
Tissue engineering, skin 1: 735
Tissue engineering, stem cell populations for 2: 783—784
Tissue engineering, techniques 1: 737 2:
Tissue engineering, techniques, activation of endogenous stem cells 2: 787—788
Tissue engineering, techniques, bioreactors 2: 786—787
Tissue engineering, techniques, cell delivery 2: 785—787
Tissue engineering, techniques, cellular replacement 1: 737—738
Tissue engineering, techniques, closed systems 1: 740
Tissue engineering, techniques, scaffold-based systems 1: 739—740 1: 1: 1: 2:
Tissue engineering, tooth regeneration 2: 286—287 2:
Tongue 2: 8 2:
Totipotency 1: 16
Totipotency in stem cell definition 2: 2
Totipotency of processed lipoaspirate cells 2: 438—439
Totipotency, defined 1: 573
Totipotency, ES cell potential 1: 626 1:
Totipotency, loss of, in differentiation 1: 640
Trachea development 1: 379
Transactivation/transformation domain-associated protein 2: 108—109
Transcriptional regulation in adult stem cell fate decisions 2: 85 2:
Transcriptional regulation in B cell development 2: 95—100
Transcriptional regulation in differentiation of ES cells in adipocytes 1: 329—333
Transcriptional regulation in hepatogenesis 2: 503—506
Transcriptional regulation in leukemogenesis 2: 315—316
Transcriptional regulation in multilineage priming 2: 85—87
Transcriptional regulation in yolk sac hematopoietic development 2: 160—161
Transcriptional regulation of connexin genes 1: 107
Transcriptional regulation of SCL gene 2: 310—312 2:
Transcriptional regulation, artificial regulatory circuits for 2: 37—38
Transcriptional regulation, cell cycle checkpoints 2: 119—121
Transcriptional regulation, chromatin-modifying factors in 1: 63—81
Transcriptional regulation, CNS development 2: 192—199
Transcriptional regulation, DNA methylation in 1: 68—69
Transcriptional regulation, downstream pathways 1: 581—582
Transcriptional regulation, embryonic kidney development 1: 338—340
Transcriptional regulation, endoderm development 1: 371—372
Transcriptional regulation, epigenetic processes 1: 72—81
Transcriptional regulation, essential stem cell properties 1: 362
Transcriptional regulation, future research 2: 38—39
Transcriptional regulation, gastrointestinal development 1: 371—373 1:
Transcriptional regulation, gene activation mechanism 2: 98—99
Transcriptional regulation, global gene expression profiles 2: 90
Transcriptional regulation, hematopoietic stem cells 2: 309—316
Transcriptional regulation, histone acetyltransferases in 2: 105 2:
Transcriptional regulation, histone modification in 1: 69—70
Transcriptional regulation, interactions in cell fate specification 2: 362
Transcriptional regulation, intestinal stem cells 2: 532—535
Transcriptional regulation, lung development 1: 383
Transcriptional regulation, network connectivity in 2: 35—36
Transcriptional regulation, neural crest cell development 2: 206—207 2:
Transcriptional regulation, posttranscriptional mechanisms 2: 38
Transcriptional regulation, preimplantation 1: 146—148
Transcriptional regulation, purpose 2: 95
Transcriptional regulation, telomerase 2: 130
Transcriptional regulation, testis development 1: 179
Transcriptional regulation, thymus and parathyroid specification 1: 393—394
|
|
|
| Ðåêëàìà |
|
|
|
|
|
|
|
|
Î ïðîåêòå